NASDAQ: CGEMCullinan Therapeutics Inc Stock Ownership - Who owns Cullinan Therapeutics?
Insider buying vs selling
Have Cullinan Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jennifer Michaelson | Chief Scientific Officer | 2026-01-22 | 4,000 | $12.30 | $49.20kSell |
| Mary Kay Fenton | Chief Financial Officer | 2025-12-31 | 27 | $6.49 | $175.23Buy |
| Nadim Ahmed | President and CEO | 2025-12-23 | 9,922 | $10.01 | $99.32kSell |
| Jennifer Michaelson | Chief Scientific Officer | 2025-12-19 | 1,345 | $10.01 | $13.46kSell |
| Jacquelyn L. Sumer | Chief Legal Officer | 2025-12-18 | 3,480 | $9.67 | $33.65kSell |
| Jennifer Michaelson | Chief Scientific Officer | 2025-12-18 | 2,898 | $9.67 | $28.02kSell |
| Jeffrey Alan Jones | Chief Medical Officer | 2025-12-18 | 4,632 | $9.67 | $44.79kSell |
| Jennifer Michaelson | Chief Scientific Officer | 2025-12-15 | 995 | $11.90 | $11.84kSell |
| Jennifer Michaelson | Chief Scientific Officer | 2025-12-12 | 2,148 | $12.38 | $26.59kSell |
| Jennifer Michaelson | Chief Scientific Officer | 2025-11-24 | 4,000 | $12.30 | $49.20kSell |
CGEM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CGEM insiders and whales buy or sell their stock.
CGEM Shareholders
What type of owners hold Cullinan Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ansbert Gadicke | 27.35% | 16,157,644 | $203.10M | Insider |
| Lynx1 Capital Management LP | 15.17% | 8,963,500 | $112.67M | Insider |
| Ubs Oncology Impact Fund LP | 12.95% | 7,648,268 | $96.14M | Insider |
| Mpm Bioimpact LLC | 12.95% | 7,648,268 | $96.14M | Institution |
| Lynx1 Capital Management LP | 9.76% | 5,766,090 | $72.48M | Institution |
| Bvf Inc | 9.73% | 5,750,683 | $72.29M | Institution |
| Morana Jovanembiricos | 7.84% | 4,631,022 | $58.21M | Insider |
| Vision Scs F2 | 7.58% | 4,476,350 | $56.27M | Insider |
| F2 Bioscience I 2017 Ltd | 7.50% | 4,430,964 | $55.70M | Insider |
| Blackrock Inc | 7.06% | 4,169,962 | $52.42M | Institution |
CGEM vs Biotech Stocks
Cullinan Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.